Xinyi Du-Harpur

771 total citations
8 papers, 427 citations indexed

About

Xinyi Du-Harpur is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xinyi Du-Harpur has authored 8 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Xinyi Du-Harpur's work include Single-cell and spatial transcriptomics (3 papers), Cutaneous Melanoma Detection and Management (3 papers) and T-cell and B-cell Immunology (2 papers). Xinyi Du-Harpur is often cited by papers focused on Single-cell and spatial transcriptomics (3 papers), Cutaneous Melanoma Detection and Management (3 papers) and T-cell and B-cell Immunology (2 papers). Xinyi Du-Harpur collaborates with scholars based in United Kingdom, United States and Germany. Xinyi Du-Harpur's co-authors include Fiona M. Watt, Magnus Lynch, Nicholas M. Luscombe, Clarisse Gânier, Rakesh Patalay, Bo Wan, Sarah Richardson, David Meagher, Sarah Coveney and Andrew Teodorczuk and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xinyi Du-Harpur

7 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyi Du-Harpur United Kingdom 6 127 80 66 65 54 8 427
Mauro Morassi Italy 9 93 0.7× 41 0.5× 34 0.5× 42 0.6× 22 0.4× 16 651
J Kunze Germany 10 48 0.4× 47 0.6× 21 0.3× 56 0.9× 10 0.2× 30 537
Michael Co Hong Kong 15 134 1.1× 95 1.2× 65 1.0× 50 0.8× 4 0.1× 56 738
Philipp Jansen Germany 15 442 3.5× 78 1.0× 69 1.0× 162 2.5× 4 0.1× 37 807
John L. Burns United States 10 42 0.3× 44 0.6× 35 0.5× 28 0.4× 4 0.1× 17 510
Alexander Delides Greece 10 90 0.7× 14 0.2× 25 0.4× 23 0.4× 5 0.1× 56 342
Katarzyna Sklinda Poland 11 39 0.3× 13 0.2× 54 0.8× 20 0.3× 24 0.4× 44 422
Behrus Puladi Germany 11 26 0.2× 49 0.6× 57 0.9× 99 1.5× 2 0.0× 53 544
Alexander Swistel United States 17 152 1.2× 100 1.3× 57 0.9× 28 0.4× 17 0.3× 48 1.1k
Eyal Fisher Israel 8 49 0.4× 8 0.1× 12 0.2× 44 0.7× 6 0.1× 14 345

Countries citing papers authored by Xinyi Du-Harpur

Since Specialization
Citations

This map shows the geographic impact of Xinyi Du-Harpur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyi Du-Harpur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyi Du-Harpur more than expected).

Fields of papers citing papers by Xinyi Du-Harpur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyi Du-Harpur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyi Du-Harpur. The network helps show where Xinyi Du-Harpur may publish in the future.

Co-authorship network of co-authors of Xinyi Du-Harpur

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyi Du-Harpur. A scholar is included among the top collaborators of Xinyi Du-Harpur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyi Du-Harpur. Xinyi Du-Harpur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Gânier, Clarisse, Xinyi Du-Harpur, Pawan Dhami, et al.. (2024). Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade. Nature Communications. 15(1). 913–913. 38 indexed citations
3.
Gânier, Clarisse, Pavel Mazin, Xinyi Du-Harpur, et al.. (2024). Multiscale spatial mapping of cell populations across anatomical sites in healthy human skin and basal cell carcinoma. Proceedings of the National Academy of Sciences. 121(2). e2313326120–e2313326120. 26 indexed citations
4.
Peng, Dandan, Cai He, Zimin Chen, et al.. (2024). XBB.1.16‐RBD‐based trimeric protein vaccine can effectively inhibit XBB.1.16‐included XBB subvariant infection. SHILAP Revista de lepidopterología. 5(9). e687–e687. 4 indexed citations
5.
Sipilä, Kalle, Emanuel Rognoni, Johanna Jokinen, et al.. (2022). Embigin is a fibronectin receptor that affects sebaceous gland differentiation and metabolism. Developmental Cell. 57(12). 1453–1465.e7. 11 indexed citations
6.
Du-Harpur, Xinyi, Fiona M. Watt, Nicholas M. Luscombe, & Magnus Lynch. (2020). What is AI? Applications of artificial intelligence to dermatology. British Journal of Dermatology. 183(3). 423–430. 195 indexed citations
7.
Wan, Bo, Clarisse Gânier, Xinyi Du-Harpur, et al.. (2020). Applications and future directions for optical coherence tomography in dermatology*. British Journal of Dermatology. 184(6). 1014–1022. 89 indexed citations
8.
Du-Harpur, Xinyi, Sarah Coveney, Niamh O’Regan, et al.. (2014). Validation of a Consensus Method for Identifying Delirium from Hospital Records. PLoS ONE. 9(11). e111823–e111823. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026